For International Students

At The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James), our nationally and internationally recognized multidisciplinary team of specialists, sub-specialists, researchers, scientists and educators combine their collective expertise to lead the nation in transforming oncology education, training and research.

Cancer is complex, and today, it is no longer solely defined by location or even by stage. That’s why finding and delivering the most effective new strategies for cancer prevention, detection, diagnosis and treatment all begin with one of the world’s top CCCs, the experts inside and the education and training they provide.

The OSUCCC – James offers several programs for international students interested in cancer research that engages with nationally and internationally recognized investigators collaborating across departments, colleges, universities and research facilities worldwide – both at the basic science and clinical science levels – and with an innovative bench-to-bedside approach to cancer discoveries, treatment and care.

Click on the links below for more program information.

International Postdocs

Postdoctoral researchers who come to The Ohio State University become affiliated with a renowned academic medical center that’s also one of the nation’s leading public research universities. At Ohio State, postdocs are well-positioned and supported to make significant basic, translational and clinical research discoveries.

Read More

The Ohio State University Comprehensive Cancer Center (OSUCCC) is a network of five interdisciplinary, cancer-related research programs

These programs collectively comprise more than 300 highly trained researchers and scientists representing 11 of the 15 colleges at Ohio State – all with the shared goal to understand what makes each patient’s cancer grow, spread or reoccur by utilizing basic, clinical, prevention and population research that translates to innovative, leading-edge care and cancer-prevention strategies.

The OSUCCC is one of only 51 CCCs in the nation as designated by the National Cancer Institute (NCI). The designation was most recently renewed in 2015, when NCI rated Ohio State’s cancer program as Exceptional, the highest descriptor.

Additionally, the OSUCCC – James is one of only a handful of U.S. cancer centers that is NCI-funded to conduct phase I and phase II clinical trials. These trials go only to centers that demonstrate an exemplary capacity for research and clinical care, the expertise to deliver the latest treatments, and the infrastructure to interpret and track results.

Because of these phase I and phase II approvals, the OSUCCC - James experts can move research discoveries into clinical trials faster and get them to patients sooner.

Contact Us

Kellee Gauthier, MPH
Admin Director, CAMELOT


614-293-9947
Email Kellee

Lawrence Kirschner, MD, PhD

CAMELOT Director


Lawrence Kirschner

 

Dr. Kirschner is a physician-scientist and clinical endocrinologist who specializes in treating patients with pituitary and adrenal tumors. He is also the director of the CAMELOT Program and a member of the Cancer Biology Program at the OSUCCC – James.

Learn More

Kellee Gauthier, MPH

CAMELOT Admin Director


Kellee Gauthier

Kellee directs, manages and oversees the administrative, programmatic and operational activities of CAMELOT, working closely with CCC leadership to provide strategic leadership.